A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro

Cancer Biotherapy & Radiopharmaceuticals
Tapan K NayakRobert W Atcher


The somatostatin analog [DOTA(0)-Tyr(3)]-octreotide (DOTATOC) has been widely used to target somatostatin receptor expressing tumors for therapy using radionuclides such as (90)Y or (177)Lu. This aim of this study was to compare the effects of DOTATOC labeled to high linear energy transfer (LET) alpha-emitter (213)Bi and low-LET beta-emitter (177)Lu in vitro. Somatostatin receptor (sstr)-positive cell line Capan-2 and sstr-negative control cell line A549 were used for the experiments. The effects of two exposure times using different radiation doses of high-LET alpha-emitter (213)Bi and low-LET beta-emitter (177)Lu were investigated using cell survival assay. The apoptotic effects were investigated using Cell Death Detection ELISA(PLUS)10x. The cumulated activity and the mean absorbed dose per unit cumulated activity were calculated using MIRD cellular Svalues. (213)Bi-DOTATOC had an approximately four times greater induction of apoptosis than (177)Lu-DOTATOC and a 100 times greater induction of apoptosis than nonradiolabeled DOTATOC. Nonspecific radiolabeled tetra-azacyclododecanetetra-acetic acid (DOTA) had a less pronounced effect on the cell survival and apoptosis, as compared to the sstr-specific radiolabeled DOTATOC. (213...Continue Reading


Jan 1, 1979·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·E L LloydB J Zabransky
Mar 1, 1982·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·Darrell R Fisher, R Harty
Jan 1, 1996·Nuclear Medicine Communications·B J Allen, N Blagojevic
Sep 2, 1998·European Journal of Nuclear Medicine·M R McDevittD A Scheinberg
Nov 7, 1999·European Journal of Nuclear Medicine·A OtteJ Muller
Aug 6, 2000·Cell and Tissue Research·M Verheij, H Bartelink
May 11, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Tilmann SchumacherHelmut R Maecke
Apr 5, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Wouter A P BreemanEric P Krenning
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Nov 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Astrid CapelloMarion De Jong
Jan 10, 2004·Endocrine-related Cancer·V J Lewington
May 22, 2004·Annals of the New York Academy of Sciences·Eric P KrenningMarion De Jong


May 13, 2014·Immunotherapy·Christof Seidl
Mar 31, 2010·Seminars in Nuclear Medicine·Ekaterina Dadachova
Nov 29, 2015·Hematology/oncology Clinics of North America·Dik J Kwekkeboom, Eric P Krenning
Apr 16, 2013·Best Practice & Research. Clinical Gastroenterology·Hendrik BergsmaDik J Kwekkeboom
Aug 17, 2019·Drug Development and Industrial Pharmacy·Ahmed A H Abdellatif
Jun 13, 2009·Journal of Receptor and Signal Transduction Research·Alex N Eberle, Gabriele Mild
Sep 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Romain EychenneNicolas Lepareur
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean R StarkeyCharles W Spangler

Related Concepts

SMT 487
Alpha Radiation
Beta Particle
Cell Nucleus
Cell Survival
Dose-Response Relationship, Radiation
Energy Transfer
Enzyme-Linked Immunosorbent Assay

Related Feeds


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jeffrey P NorenbergLarry K Kvols
European Journal of Nuclear Medicine
A OtteJ Muller
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
I KeydarH J Brenner
© 2021 Meta ULC. All rights reserved